Year: 2022

Coop Pank AS results for November 2022

Written by Customer Service on December 12, 2022. Posted in Public Companies.

Coop Pank’s financial results in November 2022:In November, number of the bank’s clients increased by 3100 and number of active clients increased by 1900. By the end of the month number of clients reached 144,700 and number of active clients reached 65,600. Over the year, customer base has grown by 29%. Volume of the bank’s customer deposits increased by 68 million euros, reaching 1.46 billion euros by the end of month. Deposits of corporate customers increased by 2 million euro and deposits of private customers increased by 21 million euros. The volume of deposits attracted from international platforms increased by 45 million euros. Over the year, volume of bank deposits has grown by 38%. The bank’s loan portfolio increased by 29 million euros over the month and reached 1.27 billion euros by the end of month. Home...

The net value of EfTEN Real Estate Fund III AS shares as of 30.11.2022

Written by Customer Service on December 12, 2022. Posted in Public Companies.

Comment from the fund manager, Viljar Arakas: During this week, the extraordinary general meetings of EfTEN Real Estate Fund III AS and EfTEN Kinnisvarafond AS are taking place, deciding on the merger of the two funds into the largest commercial real estate fund in the Baltic States. In light of the planned merger, in addition to the regular financial results of EfTEN Real Estate Fund III AS, we also present the consolidated unaudited financial results of EfTEN Kinnisvarafond AS for the 11 months of 2022 along with other important metrics. We believe that publishing the results of both funds to be merged before the general meetings gives shareholders a good opportunity to compare the latest financial indicators of the funds and their dynamics. We are convinced that the merger of the funds is in the best interest of the shareholders of...

Long-term safety and tolerability results with daridorexant in patients with insomnia disorder published in CNS Drugs

Written by Customer Service on December 12, 2022. Posted in Public Companies.

Daridorexant, taken every night for up to 12 months, was well-tolerated with no signs of tolerance (loss of effect) or physical dependence, and no evidence of withdrawal or rebound insomnia upon treatment discontinuation Exploratory efficacy endpoints show sustained improvements in nighttime sleep variables and daytime functioningAllschwil, Switzerland – December 12, 2022Idorsia Ltd (SIX: IDIA) today announced the publication of “Long-term safety and tolerability of daridorexant in patients with insomnia disorder” in CNS Drugs1. The publication reports the results from the 40-week safety extension study with daridorexant in patients with insomnia disorder, which found that treatment with daridorexant, taken every night for up to 12 months, was well tolerated, consistent with the 12-week study findings as published by Mignot, E., et...

[Ad hoc announcement pursuant to Art. 53 LR] Roche: Changes in the Board of Directors and the Corporate Executive Committee

Written by Customer Service on December 12, 2022. Posted in Public Companies.

Board of Directors Basel, 12 December 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that at its December meeting, the Board of Directors of Roche Holding Ltd has approved to propose the following changes at the Annual General Meeting on 14 March 2023: As previously announced in July 2022, Christoph Franz has decided not to seek re-election as Chairman. The Board of Directors will propose Severin Schwan as the new Chairman at the Annual General Meeting in 2023, and has appointed Thomas Schinecker as the new Roche Group CEO effective 14 March 2023. The Board of Directors will propose Mark Schneider, CEO of Nestle S.A., and Prof. Akiko Iwasaki, Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University, and Howard Hughes Medical Institute Investigator, for election as new Board...

Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022

Written by Customer Service on December 12, 2022. Posted in Public Companies.

Updated data from the phase III POLARIX study continue to demonstrate a statistically significant reduction in the risk of disease worsening or death for people with previously untreated diffuse large B-cell lymphoma (DLBCL)1 Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes, during and after fixed-duration treatment, to those receiving the current standard-of-care, with superior progression-free survival2Basel, 12 December 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new and updated data for its first-in-class anti-CD79b antibody-drug conjugate Polivy® (polatuzumab vedotin) were presented at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition, 10-13 December. Data from the POLARIX study support the potential benefit of Polivy in...

Semiconductor Gases Market to Worth USD 15.56 Billion by 2029 | Semiconductor Gases Industry CAGR of 7.5%

Written by Customer Service on December 12, 2022. Posted in Mergers And Acquisitions.

Companies covered in semiconductor gases market are Air Liquide (France) Air Products and Chemicals, Inc. (U.S.) Linde plc (U.K.) Solvay (Belgium) Iwatani Corporation (Japan) Messer Group (Germany) American Gas Products (U.S.) Electronic Fluorocarbons, LLC (U.S.) SUMITOMO SEIKA CHEMICALS CO., LTD. (Japan) Taiyo Nippon Sanso JFP Corporation (Japan) SHOWA DENKO K.K. (Japan) and many more Pune, India, Dec. 12, 2022 (GLOBE NEWSWIRE) — The global semiconductor gases market size was valued at USD 8.71 billion in 2021. The market is projected to grow from USD 9.36 billion in 2022 to USD 15.56 billion by 2029, exhibiting a CAGR of 7.5% during the forecast period. This information is provided by Fortune Business Insights, in its report titled, “Semiconductor Gases Market, 2022-2029.” COVID-19 Impacts: Supply-Chain Breakdowns Lockdown Restrictions...

Caustic Soda Market to Reach USD 55,557.7 Million by 2027 | Exhibiting a CAGR of 3.1% by 2027

Written by Customer Service on December 12, 2022. Posted in Mergers And Acquisitions.

Companies covered in the Caustic Soda Market Olin Corporation, Tata Chemicals Limited, Aditya Birla Chemicals, Gujarat Alkalies and Chemical Limited, Occidental Petroleum Corporation, Formosa Plastics Corporation, PPG Industries, Xinjiang Zhongtai Chemical, Hanwha Chemical, Brenntag North America and more players profiled Pune, India, Dec. 12, 2022 (GLOBE NEWSWIRE) — The global caustic soda market is set to gain momentum from its increasing usage as a water treatment chemical. It can absorb water and carbon dioxide and surge its pH level. This information is given by Fortune Business Insights™ in a new report, the report further states that the market size was USD 44,959.2 million in 2019 and is projected to reach USD 55,557.7 million by 2027, exhibiting a CAGR of 3.1% during the forecast period. List of Key Players Mentioned...

Proactive news headlines including Flynn Gold, Celsius Resources, Galileo Mining and NickelSearch

Written by Customer Service on December 12, 2022. Posted in Mergers And Acquisitions.

Sydney, Dec. 12, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Flynn Gold Ltd (ASX:FG1) has more than doubled on discovering a new zone of gold mineralisation at the Trafalgar prospect, part of the company’s Golden Ridge Project in northeast Tasmania, hitting up to 12.3 metres at 16.8 g/t gold, including visible gold in some intersections. Click here Celsius Resources Ltd (ASX:CLA) has revealed an updated mineral resource estimate (MRE) for the MCB Copper-Gold Project on the island of Luzon in the Philippines, held under its Philippine subsidiary company, Makilala Mining Co. Inc (MMCI). Click here Galileo Mining Ltd (ASX:GAL) is trading higher after intersecting its highest-grade nickel sulphide during drilling at...

E-bike Market worth $80.6 billion by 2027– Exclusive Report by MarketsandMarkets™

Written by Customer Service on December 12, 2022. Posted in Dividend Reports And Estimates.

Chicago, Dec. 11, 2022 (GLOBE NEWSWIRE) — E-bike Market size is projected to reach USD 80.6 billion by 2027 from an estimated USD 49.7 billion in 2022, at a CAGR of 10.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. Browse and in-depth TOC on “E-bike Market” 415 – Tables 65 – Figures 371 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id= 110827400 Scope of the Report:Report Attributes DetailsMarket size value in 2022: USD 49.7 BillionProjected to reach 2027: USD 80.6 BillionCAGR: 10.2%Base Year Considered: 2021Forecast Period: 2022-2027Largest Market: Asia PacificRegion Covered: Asia Pacific, North America, Europe, and RoWSegments Covered: Class, Speed, Battery Type, Motor Type,...

Agios Presents Updated PYRUKYND® (mitapivat) Long-term Extension Data Demonstrating Sustained Clinical Benefits in Adults with Pyruvate Kinase (PK) Deficiency at 64th ASH Annual Meeting and Exposition

Written by Customer Service on December 12, 2022. Posted in Public Companies.

– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with Improvements in Hemoglobin, Iron Overload, Transfusion Burden and Patient-reported Outcomes, Regardless of Transfusion Status – – Additional Data Presented at ASH Characterize Disease Complications and Co-morbidities of PK Deficiency in Pediatric Populations, Supporting Ongoing Pivotal ACTIVATE-Kids and ACTIVATE-KidsT Studies of PYRUKYND®– – Agios to Host Live and Webcast Investor Event on Dec. 12, 2022, at 7 a.m. CT – CAMBRIDGE, Mass., Dec. 11, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today reported new data from the ongoing extension study assessing the long-term efficacy and safety of PYRUKYND® (mitapivat) in adults with...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals